Angitia Biopharmaceuticals

formerly Angitia

Innovation for Patients

Westlake Village, United States · Founded 2018 · $506.0M raised

Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$506.0M
Last Round
$130.0M Series DFeb 2026
Rounds
8

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on discovering and developing innovative therapeutics for musculoskeletal diseases including osteoporosis, osteogenesis imperfecta, and spinal fusion. The company's pipeline features bispecific antibody candidates in Phase 2 clinical trials, with offices in Westlake Village, California and Guangzhou, China.

Summary

Angitia Biopharmaceuticals is a Biotech company based in Westlake Village, United States, founded in 2018. It has raised $506.0M in total across 8 rounds, most recently a $130.0M Series D round in Feb 2026. Investors include Bain Capital Life Sciences, Morningside Group and Frazier Life Sciences.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DFeb 2026
$130.0M

Sign up to see all 8 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Angitia Biopharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/angitia-biopharmaceuticals"><img src="https://indexed.vc/api/badge/company/angitia-biopharmaceuticals" alt="Angitia Biopharmaceuticals on Indexed.vc" width="260" height="76" /></a>